Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma.
König D, Kasenda B, Sandholzer M, Chirindel A, Zingg A, Ritschard R, Thut H, Glatz K, Kappos EA, Schaefer D, Kettelhack C, Passweg J, Baur K, Holbro A, Buser A, Lardinois D, Jeker LT, Khanna N, Stenner F, Matter MS, Rodrigues Mantuano N, Binder M, Zippelius A, Läubli H.
König D, et al. Among authors: glatz k.
Immunooncol Technol. 2024 Aug 22;24:100728. doi: 10.1016/j.iotech.2024.100728. eCollection 2024 Dec.
Immunooncol Technol. 2024.
PMID: 39801681
Free PMC article.